Vanderbilt-Ingram Cancer Ctr
Vanderbilt-Ingram Cancer Ctr
Nashville, Tennessee, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers | PIK3CA-Mutated Cancers | Active, not recruiting | Phase 1 | 2026-08-20 | NCT06496568 |